Can Fite (Israel) Performance

CANF -- Israel Stock  

ILS 238.90  0.40  0.17%

Can Fite has performance score of 0 on a scale of 0 to 100. The firm shows Beta (market volatility) of 0.3898 which signifies that as returns on market increase, Can Fite returns are expected to increase less than the market. However during bear market, the loss on holding Can Fite will be expected to be smaller as well.. Although it is extremely important to respect Can Fite BioPharma historical returns, it is better to be realistic regarding the information on equity current trending patterns. The philosophy towards foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By analyzing Can Fite BioPharma technical indicators you can presently evaluate if the expected return of 0.0318% will be sustainable into the future. Can Fite BioPharma right now shows a risk of 2.9948%. Please confirm Can Fite BioPharma Standard Deviation, Information Ratio, Treynor Ratio, as well as the relationship between Variance and Jensen Alpha to decide if Can Fite BioPharma will be following its price patterns.
Horizon     30 Days    Login   to change

Can Fite BioPharma Relative Risk vs. Return Landscape

If you would invest  23,960  in Can Fite BioPharma Ltd on November 16, 2018 and sell it today you would lose (70.00)  from holding Can Fite BioPharma Ltd or give up 0.29% of portfolio value over 30 days. Can Fite BioPharma Ltd is generating 0.0318% of daily returns and assumes 2.9948% volatility on return distribution over the 30 days horizon. Simply put, 27% of equities are less volatile than Can Fite BioPharma Ltd and 99% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
      Risk (%) 
Assuming 30 trading days horizon, Can Fite BioPharma Ltd is expected to generate 2.32 times more return on investment than the market. However, the company is 2.32 times more volatile than its market benchmark. It trades about 0.01 of its potential returns per unit of risk. The DOW is currently generating roughly -0.11 per unit of risk.

Can Fite Market Risk Analysis

Sharpe Ratio = 0.0106
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsCANF

Can Fite Relative Performance Indicators

Estimated Market Risk
 2.99
  actual daily
 
 27 %
of total potential
 
27
Expected Return
 0.03
  actual daily
 
 0 %
of total potential
 
0
Risk-Adjusted Return
 0.01
  actual daily
 
 0 %
of total potential
 
0
Based on monthly moving average Can Fite is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Can Fite by adding it to a well-diversified portfolio.

Can Fite Performance Rating

Can Fite BioPharma Ltd Risk Adjusted Performance Analysis

0

Risk-Adjusted Performance

Over the last 30 days Can Fite BioPharma Ltd has generated negative risk-adjusted returns adding no value to investors with long positions.

Can Fite Alerts

Equity Alerts and Improvement Suggestions

Can Fite BioPharma is not yet fully synchronised with the market data
The company reported revenue of 1.55M. Net Loss for the year was (5.84M) with profit before overhead, payroll, taxes, and interest of 789K.
CAN-FITE BIOPHARMA has accumulated about 5.84M in cash with (5.38M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.15.

Can Fite Performance Indicators

Can Fite BioPharma Basic Price Performance Measures

Quick Ratio4.23
Fifty Two Week Low214.00
Target High Price6.00
Fifty Two Week High432.80
Target Low Price6.00
Check also Trending Equities. Please also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.
Search macroaxis.com